Published in Ter Arkh on January 01, 2016
Acetylator phenotype in patients with breast cancer. Oncology (1978) 0.92
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
[Virulence of Mycobacteria tuberculosis]. Probl Tuberk (2002) 0.83
The ultrastructural organization of sympathetic ganglia of the cat. J Auton Nerv Syst (1982) 0.81
[An electron microscopic analysis of the synapses of the inferior mesenteric sympathetic ganglion as an afferent component of sympathetic reflexes]. Neirofiziologiia (1974) 0.79
[Ultrastructure of sensory endings in sympathetic ganglia]. Arkh Anat Gistol Embriol (1980) 0.77
[Combined therapy of pulmonary tuberculosis by using recombinant interleukins]. Probl Tuberk Bolezn Legk (2003) 0.77
Activity of N-acetyltransferase in patients with malignant lymphomas. Neoplasma (1978) 0.77
[Pulmonary tuberculosis caused by Mycobacterium tuberculosis of different genotypes]. Probl Tuberk Bolezn Legk (2003) 0.77
[Role of Helicobacter pylori in the etiology of duodenal ulcer recurrence after selective proximal vagotomy]. Khirurgiia (Mosk) (1996) 0.76
[In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria]. Antibiot Khimioter (1991) 0.76
[Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.76
[Effectiveness of new diagnostic drug Diaskintest in children for tuberculosis diagnostic]. Probl Tuberk Bolezn Legk (2009) 0.76
[Comparative efficacy of clinical use of reamberin, remaxol and ademethionine in patients with tuberculosis of the respiratory organs and liver drug-injury]. Antibiot Khimioter (2013) 0.75
[Carboxy mimetic derivatives of nucleic acid polymeric backbones inhibiting human cytomegalovirus. 1. In vitro microbicidal effect]. Antibiot Khimioter (2007) 0.75
[Diagnosis and treatment of urinary bladder dysfunctions in patients with nephrotuberculosis]. Urologiia (2007) 0.75
[Role of a comprehensive genetic prognosis in the treatment and prevention of respiratory tuberculosis in adolescents]. Probl Tuberk Bolezn Legk (2005) 0.75
[Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis]. Ter Arkh (1994) 0.75
[Pharmacological activity of runihol and S-adenosyl-L-methionine in rats with experimental liver damage by reserve antituberculosis drugs]. Eksp Klin Farmakol (2013) 0.75
[Comparative effectiveness of etiopathogenetic therapy in adolescents with destructive pulmonary tuberculosis]. Probl Tuberk (1994) 0.75
[The course of pulmonary tuberculosis in adolescents]. Probl Tuberk (1994) 0.75
[Peculiarities of newly detected primary tuberculosis in children]. Pediatriia (1969) 0.75
[Activating effect of bestim on the macrophages in experimental tuberculosis of varying severity]. Probl Tuberk Bolezn Legk (2003) 0.75
[The clinical laboratory comparison in the assessment of treatment prognosis in patients with infiltrative tuberculosis of lungs]. Klin Lab Diagn (2012) 0.75
[Course of sarcoidosis in childhood, adolescence and young adulthood]. Pediatriia (1982) 0.75
[Lymph node tuberculosis of the ductus arteriosus in children]. Probl Tuberk (1981) 0.75
[Effect of plasmapheresis on the course of experimental tuberculosis and the tolerance of chemotherapy by patients with renal tuberculosis]. Probl Tuberk (1992) 0.75
[Clinical and laboratory study of cefodizime (Modivid) in prophylaxis and treatment of surgical patients]. Antibiot Khimioter (1998) 0.75
[Antiviral activity of polycarboxylic substances modified by cage hydrocarbon and sulfoacid pharmacophors against cytomegalovirus infection in vitro]. Antibiot Khimioter (2008) 0.75
[Method of determining the activity of primary tuberculosis in children]. Probl Tuberk (1971) 0.75
[The hepatoprotective activity of remaxol and S-adenosyl-L-methionine for liver damage caused by reserve-series antituberculosis drugs]. Arkh Patol (2013) 0.75
[Difficulties in diagnosing minor forms of primary intrathoracic tuberculosis in children]. Probl Tuberk (1980) 0.75
[Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis]. Probl Tuberk (1999) 0.75
[Laboratory and clinical study of nitazole]. Antibiot Khimioter (1998) 0.75
[Immunogenetic aspects of the course and treatment of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[Anti-tuberculous activity of amikacin]. Probl Tuberk (1986) 0.75
[Peculiarities of the circulating phagocytes functional activity in patients with different forms of drug-resistant pulmonary tuberculosis]. Biomed Khim (2013) 0.75
In silico analysis of the structure of variable domains of mouse single-chain antibodies specific to the human recombinant interferon beta1b. Tsitol Genet (2009) 0.75
[Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia]. Ter Arkh (2001) 0.75
[Immunotropic and antihypoxant therapy of experimental drug-sensitive and drug-resistant tuberculosis]. Patol Fiziol Eksp Ter (2013) 0.75
[The effectiveness of influenza vectors expressing the protective mycobacterial antigen ESAT-6 in the complex therapy of generalized tuberculosis in mice]. Probl Tuberk Bolezn Legk (2008) 0.75
[Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents]. Probl Tuberk (1995) 0.75
[Obtaining of ScFv-CBD fusion protein and its application for affinity purification of recombinant human interferon alpha2b]. Ukr Biokhim Zh (1999) (2006) 0.75
[Overproduction of single-chain antibodies against human IFN-alpha2B in Escherichia coli and their isolation in biologically active form]. Ukr Biokhim Zh (1999) (2006) 0.75
[Characteristics of intrathoracic tuberculosis in children]. Probl Tuberk (1982) 0.75
[Antimicrobial chemotherapy in patients with pyo-septic diseases in intensive care units]. Khirurgiia (Mosk) (1999) 0.75
[Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation]. Klin Med (Mosk) (1998) 0.75
[Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)]. Antibiot Khimioter (2011) 0.75
[Influence of membrane-active polyanions on various stages of the human cytomegalovirus life cycle in vitro]. Antibiot Khimioter (2008) 0.75
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis]. Probl Tuberk (1993) 0.75
[Antibiotic prophylaxis and reconstructive operations in patients with burn sequelae]. Antibiot Khimioter (1994) 0.75
[Hepatotropic therapy in treatment of liver injury]. Antibiot Khimioter (2012) 0.75
[Exudative pleurisy in children]. Probl Tuberk (1979) 0.75
[Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b]. Tsitol Genet (2009) 0.75
[Prevention of tuberculosis: current approaches to development of vaccines]. Vestn Ross Akad Med Nauk (2012) 0.75
[Enhancement of the activity of antitubercular agents with other antimicrobial agents]. Probl Tuberk (1994) 0.75
[Substantiation and varieties of complex surgical treatment tactics for pyo-necrotic forms of diabetic foot]. Khirurgiia (Mosk) (1999) 0.75
Effects of hydroxypyridine derivatives mexidol and emoxypin on the reparative processes in rabbit eye on the models of corneal epithelial defect and conjunctival ischemia. Bull Exp Biol Med (2015) 0.75
[History of St. Petersburg Research Institute of Phthisiopulmonology, Ministry of Health of Russia]. Probl Tuberk Bolezn Legk (2003) 0.75
[Therapy strategy in the treatment of patients with drug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2003) 0.75
[Destructive tuberculosis of the lung in adolescents]. Probl Tuberk (1977) 0.75
[Results of clinical and laboratory studies of anaerobic non-clostridial infection in a surgical clinic]. Vestn Ross Akad Med Nauk (1996) 0.75
[Clinical and X-ray characteristics of progressive tuberculosis in teenagers]. Probl Tuberk (1999) 0.75
[Extrathoracic and disseminated sarcoidosis in children, teenagers, and adolescents]. Probl Tuberk (1982) 0.75
[The effect of runihol and exogenous S-adenosyl-L-methionine on the morphological pattern of the liver upon hepatotoxic exposure to reserve-series antituberculous drugs]. Arkh Patol (2013) 0.75
[Antimicrobial drug susceptibility of 365 Streptococcus agalactiae strains isolated in 1999-2006]. Antibiot Khimioter (2007) 0.75
[Differential diagnosis of disseminated pulmonary tuberculosis in children]. Probl Tuberk (1977) 0.75
[Blood bacteriostatic activity in patients with respiratory tuberculosis]. Probl Tuberk (2001) 0.75
[Characteristics of endogenous intoxication of adolescents with tuberculosis]. Probl Tuberk (2002) 0.75
[Comparative study of remaxol and ademethionine effects on reparative regeneration processes in the liver subjected to surgical intervention]. Eksp Klin Farmakol (2011) 0.75
[The epidemiologic significance of the resistance of tuberculosis mycobacteria to isonicotinic acid hydrazide]. Probl Tuberk (1971) 0.75
[The activity of alpha2-macroglobulin and its forms in patients with destructive pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Healthcare at water transport]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med (2005) 0.75
[A role of the HLA-DRB1* genotype in the complex therapy of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.75
[Approach to diagnosing tuberculosis of intrathoracic lymph nodes of a paraaortic group in children]. Probl Tuberk Bolezn Legk (2007) 0.75
[Construction and characterization of immune combinatorial cDNA library of mouse variable immunoglobuline genes]. Tsitol Genet (2008) 0.75
[Training of high-skilled researchers at the Saint-Petersburg Research Institute of Phtisiopulmonology in 1994-1998]. Probl Tuberk (1999) 0.75
[Investigation of remaxol efficacy in complex therapy of experimental generalized tuberculosis on mice]. Antibiot Khimioter (2012) 0.75
[Today's tuberculosis: the specific features of its pathogen, clinical picture, and treatment]. Probl Tuberk Bolezn Legk (2005) 0.75
[Effects of novel antiviral agents on HIV-1 replication]. Vopr Virusol (2009) 0.75
[Localization of human cytomegalovirus immediate-early protein IE-1 pp72 in the juxtanuclear inclusion at the late stage of infection]. Vopr Virusol (2009) 0.75
[Elastic materials in surgery for inflammatory diseases of the vertebral column]. Probl Tuberk Bolezn Legk (2006) 0.75
[Perioperative management of focal liver diseases by ofloxacin]. Antibiot Khimioter (2002) 0.75
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Pathogenetic therapy of pulmonary tuberculosis in adolescents]. Probl Tuberk (1994) 0.75
[The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)]. Antibiot Khimioter (1999) 0.75
[An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis]. Eksp Klin Farmakol (2012) 0.75
[Immunotropic activity of antimicrobial agents used in tuberculosis]. Probl Tuberk (1996) 0.75
[Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test]. Probl Tuberk Bolezn Legk (2008) 0.75
[Activities of the Tuberculosis Chair of the Central Institute of Graduate Training of Physicians 1931-1980]. Probl Tuberk (1980) 0.75
[Microflora of purulent necrotic leisions of the foot in patients with diabetes mellitus]. Antibiot Khimioter (1995) 0.75
[Clinical course of arterial hypertension in young subjects with vibration disease]. Klin Med (Mosk) (2009) 0.75
[Tuberculin reactions in diagnosis and differential diagnosis of tuberculosis in children]. Pediatriia (1976) 0.75
[Problem of osteopoikilosis]. Klin Med (Mosk) (1993) 0.75